O

Osanni Bio

Development-stage therapeutics platform advancing drug programs

Controller

Financial AccountingPosted on Nov 10
Full-timeCalifornia, USA$260k - $285k

About the Job

Requirements

  • A Bachelor's degree in Accounting or Finance is required.
  • An active Certified Public Accountant license is strongly preferred.
  • At least 12 years of progressive accounting experience, including at least 5 years as a Controller or Assistant Controller.
  • Experience in a biotech, pharmaceutical, or life sciences company, including working knowledge of research and development accruals, contract research and contract development/manufacturing organization contracts, collaboration or licensing accounting, financings, diligence, and new entity formation.
  • Knowledge of U.S. Generally Accepted Accounting Principles and experience with multi-entity accounting, intercompany transactions, and consolidations.
  • Experience managing successful external audits, building scalable internal controls, and implementing or optimizing multi-entity enterprise resource planning and finance systems; advanced Excel skills.
  • Ability to build, lead, and develop a high-performing accounting team, including managing outsourced accounting partners.
  • Ability to explain complex accounting matters clearly to non-finance partners, auditors, and the board, with a collaborative, hands-on, and adaptable working style.

Responsibilities

  • Lead monthly, quarterly, and annual close processes for Osanni and its affiliated companies, delivering accurate and timely consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles.
  • Build and maintain accounting infrastructure for the hub-and-affiliate model, including entity structure, chart of accounts, intercompany agreements, cost allocations, shared-services charge-backs, consolidation eliminations, and reconciliations across entities.
  • Partner with the Chief Financial Officer and Senior Director of Financial Planning and Analysis on budgeting, forecasting, and cash planning at hub and affiliate levels, providing analysis to support capital allocation and program decisions.
  • Design, document, and maintain internal controls and accounting policies that scale as new affiliated companies are formed, financed, or partnered.
  • Own the annual financial statement audit, quarterly reviews, and affiliate-level audits; serve as primary contact for external auditors; prepare audit-ready schedules and documentation; manage provided-by-client timelines; and resolve findings to support financings, partnerships, and public-company readiness.
  • Oversee technical accounting for research and development accruals, equity and stock-based compensation, convertible instruments, licensing and collaboration agreements, and leases under ASC 842.
  • Partner with People and Culture on payroll, benefits, and equity administration, and with Clinical, Chemistry, Manufacturing and Controls, and Research and Development leaders on contract research and contract development/manufacturing organization contracts, accruals, and vendor spend.
  • Coordinate with outside tax advisors on federal, state, and research and development credit filings, 409A valuations, and tax implications of new affiliate structures and transactions.
  • Support financings, affiliate formation, business development, and diligence by preparing financial data, entity-level reporting, and investor and board materials.
  • Select, implement, and optimize finance systems, including enterprise resource planning, accounts payable automation, and expense management, to support efficient multi-entity operations.
  • Manage multiple priorities in a fast-paced, evolving environment, ensuring deliverables are completed accurately and on time, and perform other related duties as required.

Desired Qualifications

  • Prior public accounting experience.
  • Experience with hub-and-spoke, subsidiary, or merger and acquisition accounting.

About the Company

Osanni Bio

Development-stage therapeutics platform advancing drug programs

Osanni Bio uses a centralized innovation engine paired with a network of affiliate companies to discover, de-risk, and advance drug programs to proof-of-concept, then spins out successful programs as independent companies to scale. It generates drug concepts and progresses them to PoC through its central research engine and affiliate network. Unlike traditional pharma pipelines, it combines central science with a spin-out model to pursue capital-efficient, rapid PoC development. Its goal is to accelerate medicines in ophthalmology and cardiology with efficient progression to PoC and scalable programs.

Company size
11-50
Company stage
Series B
Total funding
$217M
Headquarters
San Francisco, CA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Osanni Bio

See more jobs